Global Fund Board awards $53.3 million to three more interim applicants
David GarmaiseArticle Type:
Article Number: 4
Egypt, Suriname and Tanzania join ranks of interim funding recipients
ABSTRACT Funding of up to $53.3 million was approved for three interim applicants under the new funding model, bringing to 40 the number of applicants awarded interim funding of 48 invited to apply when the transition phase of the new funding model was launched.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its approval of funding of up to $53.3 million for three interim applicants in the transition phase of the new funding model (NFM) on 23 December.
In approving the funding, the Board was acting on recommendations from the Technical Review Panel (TRP) and the Secretariat, including the Grant Approvals Committee (GAC).
This brings to 40 the number of interim applicants to whom funding has been awarded. When the transition phase of the NFM was launched, the Global Fund said that 48 interim applicants had been invited to apply. More approvals are expected in coming months ahead of the full roll-out of the NFM, expected by mid-2014.
Tanzania’s award of $51 million for an HIV grant was by far the largest. See the table for the full breakdown.
Table: Interim Funding Awards from GAC Report GF-B30-ER2
The amounts shown are ceilings; Final commitments could be less.
Below is an overview of the awards for Egypt and Suriname. See a more detailed article about Tanzania’s award here.
Most of the $2.1 million in new funding was allocated to health products and diagnostic equipment for use in high-risk groups. The interventions are aligned to the revised National Strategic Plan 2013–2017, which aims to reduce the TB burden in Egypt from an estimated incidence of 17 per 100,000 in 2012 to 13 per 100,000 by 2017. The new funding will supplement an existing TB grant administered by the National TB Control Programme in the Ministry of Health.
Suriname will receive $173,420 to prepare for the pre-elimination phase of malaria. Specifically, the new funding will be used to: introduce a tracking component for malaria testing and treatment; improve data quality; and improve active case detection. The new funding will be added to an existing TB grant, for which the PR is the Ministry of Health, extending it until December 2014.
Information for this article was taken from Board Decisions GF-B30-EDP3 and GF-B30-EDP4 and from GF-B30-ER2, the Report of Secretariat Funding Recommendations. These documents are not available on the Global Fund website.